E Bio Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 0.50 M
as on 06-07-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 06-07-2024
- Revenue -2.04%
(FY 2023)
- Profit 94.12%
(FY 2023)
- Ebitda 211.53%
(FY 2023)
- Net Worth -4.72%
(FY 2023)
- Total Assets 1.80%
(FY 2023)
About E Bio Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 M.
Piyush Kabra, Shweta Maheshwri, Purushottam Maheshwari, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74900MH2013PLC242622
- Company No.
242622
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at E Bio Remedies?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Kabra  | Director | 29-Apr-2013 | Current |
| Shweta Maheshwri | Director | 06-Mar-2017 | Current |
| Purushottam Maheshwari | Director | 06-Mar-2017 | Current |
| Padma Kabra | Director | 21-Jun-2016 | Current |
| Kanchan Kabra | Director | 21-Jun-2016 | Current |
| Shailesh Kabra | Director | 29-Apr-2013 | Current |
Financial Performance of E Bio Remedies.
E Bio Remedies Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.04% decrease. The company also saw a substantial improvement in profitability, with a 94.12% increase in profit. The company's net worth dipped by a decrease of 4.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of E Bio Remedies?
In 2023, E Bio Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jul 2022 | Others | ₹1.00 M | Open |
How Many Employees Work at E Bio Remedies?
Unlock and access historical data on people associated with E Bio Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of E Bio Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped E Bio Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
